April 21, 2022
What stands between rare cancer patients and life-saving treatment? A 3-to-7-character alpha-numeric code.
March 24, 2022
Biomarkers are predictive markers in genetic material that can indicate which medications might work for a given patient. For cancer patients, biomarker testing is an important first step toward tailored treatment.
February 22, 2022
ICER has announced its intent to issue a final evidence report in this review without first holding a public hearing, a highly unusual decision.
February 17, 2022
Even after vowing to expand patients’ engagement in its process, the nation’s most active health technology assessment organization has shut them out.
February 8, 2022
Cancer touches people from all walks of life. But, too often, cutting-edge cancer treatments aren’t accessible to everyone equally.
January 18, 2022
In some cases, patients switch between using similar medications without thinking twice. Aspirin and ibuprofen, for example, are both over-the-counter medications for treating minor pain. But not every swap is as easy to understand.
July 22, 2021
America faces a good news-bad news situation, according to the newly published annual report from the American Cancer Society.
June 24, 2021
Biosimilars are increasing the number of safe, effective treatments for cancer.
June 24, 2021
Biosimilars offer more cancer treatment options at potentially lower prices. So why aren’t they more accessible?
May 11, 2021
The heartbreaking headline said it all: a new CAR-T personalized cancer treatment was found “effective, but too costly” by the economists at the Institute for Clinical and Economic Research.